Notable Analyst Rating Changes 06/08: (ONXX) (YHOO) (FTR) Upgraded; (NAV) (NTAP) (APD) Downgraded
Tweet Send to a Friend
UPGRADES
BofA/Merrill Lynch upgrades Onyx Pharmaceuticals (Nasdaq: ONXX) from Neutral to Buy with a price target of $57.00 (from $47.00).
This article: 277 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA/Merrill Lynch upgrades Onyx Pharmaceuticals (Nasdaq: ONXX) from Neutral to Buy with a price target of $57.00 (from $47.00).
This article: 277 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
